VTRS
NASDAQ · Pharmaceuticals
Viatris Inc
$13.36
+0.07 (+0.53%)
Performance
1D
—
1W
—
1M
—
3M
+8.44%
6M
+40.34%
1Y
+49.27%
YTD
+7.22%
Open$13.21
Previous Close$13.29
Day High$13.49
Day Low$13.11
52W High$16.47
52W Low$6.85
Volume—
Avg Volume10.99M
Market Cap15.59B
P/E Ratio—
EPS$-2.96
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$13.14
Above
SMA 200
$10.55
Above
RSI (14)
87.6
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
18 analysts
Price Target
+819.3% upside
Current
$13.36
$13.36
Target
$122.82
$122.82
$69.38
$122.82 avg
$167.78
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 14.43B | 15.06B | 3.47B |
| Net Income | -3,545,826,666 | -3,331,152,400 | 966.90M |
| Profit Margin | -24.6% | -23.4% | 27.9% |
| EBITDA | -398,822,830 | -395,492,367 | 1.51B |
| Free Cash Flow | — | — | 925.81M |
| Rev Growth | -4.2% | -4.2% | -2.8% |
| Debt/Equity | 0.98 | 0.98 | 0.35 |
Dividend
Dividend Yield3.67%
Annual Dividend$0.48
Payout Ratio28.5%
Frequencyquarterly
Ex-Dividend—
Pay Date—
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $903.02 | -0.83% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $235.27 | -0.06% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $116.37 | +0.60% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $26.96 | +0.71% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $57.39 | +0.68% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $115.93 | +0.61% | 21.5 | 57.37B |